Elmiron, manufactured by Janssen Pharmaceuticals, is prescribed for the treatment of interstitial cystitis, a painful bladder condition. Unfortunately, several studies have now linked Elmiron to a serious vision condition called pigmentary maculopathy. The presentation of pigmentary maculopathy is very similar to that of other conditions including macular degeneration and pattern dystrophy. Elmiron may not only cause pigmentary maculopathy in current users but could also cause progressive damage to the eyes after full discontinuation of the medication.
The potential diagnoses and side effects include:
- Pigmentary Maculopathy
- Retinal Maculopathy
- Macular Degeneration
- Pattern Dystrophy
- Vision Loss / Vision Impairment
- Visual disturbances
- Blurred Vision
- Blindness (unilateral or bilateral)
Please call Capretz Law Firm today for a free consultation at (800) 351-8588 or click here to leave us a message for one of our Elmiron representatives to contact you.